Tag Archives: AMGN

Top 10 Gold Stocks To Invest In Right Now

The rally in equities had stolen much of the speculative demand from gold, and any pullback promised to send investors running back into gold. This is happening at this very moment, explains Brien Lundin, editor of Gold Newsletter. Coincidental to all of this, we’ll soon see the end of two events — the Chinese New_Year […]

Top Biotech Stocks To Own Right Now

What happened ImmunoGen (NASDAQ:IMGN) is up 21.8% at 1:06 p.m. EST on no apparent news. Of course, it’s a biotech, so that’s often par for the course. So what One possibility is that day traders are just doing their thing, following the momentum, which pushes the stock price higher. We’ll know in a few days […]

Best Biotech Stocks To Buy For 2017

Today, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotechnology stockPfenex (NYSEMKT: PFNX) as a buy: With just a quick glance at Pfenex, it doesn’t look like much. Take a closer look though. There’s a method to all the volatile madness we’ve seen since the middle of the year. This back-and-forth indicates the bulls […]

Top 10 Biotech Stocks To Buy For 2017

Although 2016 wasn’t exactly the greatest year for healthcare stocks in general, there really aren’t very many true bargains to be found in the industry. However, three healthcare stocks do appear to be priced well below what they’re worth. Here’s why Gilead Sciences (NASDAQ:GILD), Lantheus Holdings (NASDAQ:LNTH), and Mallinckrodt (NYSE:MNK) look to be ridiculously cheap […]

3 Big Drugmakers Most Likely to Buy Incyte”

Which biotechs have high prospects of being acquired in the near future? Many would place Incyte (NASDAQ:INCY) near the top of the list. The company’s oncology portfolio makes it an attractive target.But a target for whom? Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY), and Amgen (NASDAQ:AMGN) stand out as three of the most likely suitors for […]